BDTX - Black Diamond Therapeutics, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Cambridge,
United States
Type: Equity
BDTX price evolution
BDTX
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $57.04 | $58.8 | $43.12 | $40.31 |
| Short term investments | $75.18 | $86.28 | $47.64 | $64.22 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $134.03 | $147.05 | $92.99 | $107.98 |
| Long term investments | ||||
| Property, plant & equipment | $23.71 | $24.51 | $25.66 | $26.44 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $24.53 | $25.33 | $26.89 | $27.61 |
| Total investments | $75.18 | $86.28 | $47.64 | $64.22 |
| Total assets | $158.57 | $172.38 | $119.88 | $135.58 |
| Current liabilities | ||||
| Accounts payable | $2.32 | $0.69 | $2.74 | $3.05 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $19.65 | $15.07 | $13.9 | $12.85 |
| Long term debt | $22.18 | $23 | $23.78 | $24.55 |
| Total noncurrent liabilities | $22.18 | $23 | $23.78 | $24.55 |
| Total debt | $22.18 | $23 | $23.78 | $24.55 |
| Total liabilities | $41.83 | $38.06 | $37.68 | $37.39 |
| Shareholders' equity | ||||
| Retained earnings | -$417.43 | -$398.02 | -$375.02 | -$355.86 |
| Other shareholder equity | -$0.03 | -$0.36 | -$0.66 | -$1.18 |
| Total shareholder equity | $116.74 | $134.32 | $82.2 | $98.19 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $57.04 | $35.48 | $67.02 | $35.83 |
| Short term investments | $75.18 | $88.49 | $143.99 | $280.46 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $134.03 | $127.71 | $215.7 | $319.55 |
| Long term investments | ||||
| Property, plant & equipment | $23.71 | $27.38 | $30.74 | $8.79 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $24.53 | $28.55 | $31.98 | $10.12 |
| Total investments | $75.18 | $88.49 | $143.99 | $280.46 |
| Total assets | $158.57 | $156.25 | $247.68 | $329.67 |
| Current liabilities | ||||
| Accounts payable | $2.32 | $1.88 | $4.11 | $2.54 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $19.65 | $15.26 | $23.64 | $14.22 |
| Long term debt | $22.18 | $25.3 | $28.14 | $7.69 |
| Total noncurrent liabilities | $22.18 | $25.3 | $28.14 | $7.69 |
| Total debt | $22.18 | $25.3 | $28.14 | $7.69 |
| Total liabilities | $41.83 | $40.56 | $51.78 | $21.91 |
| Shareholders' equity | ||||
| Retained earnings | -$417.43 | -$334.99 | -$243.82 | -$118.22 |
| Other shareholder equity | -$0.03 | -$1.82 | -$0.41 | $0.61 |
| Total shareholder equity | $116.74 | $115.69 | $195.9 | $307.76 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $15.29 | $16.15 | $13.15 | $14.75 |
| Selling, general & administrative | $5.57 | $7.86 | $6.88 | $6.81 |
| Total operating expenses | $20.86 | $24.01 | $20.03 | $21.56 |
| Operating income | -$20.86 | -$24.01 | -$20.03 | -$21.56 |
| Income from continuing operations | ||||
| EBIT | -$19.41 | -$23.01 | -$19.15 | -$20.88 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$19.41 | -$23.01 | -$19.15 | -$20.88 |
| Income (for common shares) | -$19.41 | -$23.01 | -$19.15 | -$20.88 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $59.35 | $64.44 | $96.83 | $48.21 |
| Selling, general & administrative | $27.11 | $28.39 | $30.04 | $21.36 |
| Total operating expenses | $86.46 | $92.83 | $126.87 | $69.57 |
| Operating income | -$86.46 | -$92.83 | -$126.87 | -$69.57 |
| Income from continuing operations | ||||
| EBIT | -$82.44 | -$91.17 | -$125.6 | -$67.25 |
| Income tax expense | ||||
| Interest expense | $0 | |||
| Net income | ||||
| Net income | -$82.44 | -$91.17 | -$125.6 | -$67.25 |
| Income (for common shares) | -$82.44 | -$91.17 | -$125.6 | -$67.25 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$19.41 | -$23.01 | -$19.15 | -$20.88 |
| Operating activities | ||||
| Depreciation | $0.09 | $0.12 | $0.11 | $0.12 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.54 | $2.75 | $2.65 | $2.67 |
| Total cash flows from operations | -$13.96 | -$18.36 | -$14.37 | -$20.03 |
| Investing activities | ||||
| Capital expenditures | -$0.03 | $0.1 | ||
| Investments | $12.25 | -$37.85 | $17.08 | $24.81 |
| Total cash flows from investing | $12.25 | -$37.88 | $17.18 | $24.81 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.05 | $71.93 | $0.05 | |
| Net borrowings | ||||
| Total cash flows from financing | -$0.05 | $71.93 | $0.05 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$1.75 | $15.68 | $2.81 | $4.83 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$82.44 | -$91.17 | -$125.6 | -$67.25 |
| Operating activities | ||||
| Depreciation | $0.44 | $0.51 | $0.2 | $0.05 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $9.6 | $12.2 | $14.04 | $7.76 |
| Total cash flows from operations | -$66.72 | -$85.08 | -$100.15 | -$52.15 |
| Investing activities | ||||
| Capital expenditures | $0.06 | -$0.18 | -$2.71 | -$0.14 |
| Investments | $16.28 | $53.55 | $133.32 | -$281.55 |
| Total cash flows from investing | $16.35 | $53.37 | $130.61 | -$281.69 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $71.93 | $0.18 | $0.73 | $214.94 |
| Net borrowings | ||||
| Total cash flows from financing | $71.93 | $0.18 | $0.73 | $214.94 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $21.56 | -$31.54 | $31.19 | -$118.89 |
News
Fundamentals
| Market cap | $273.72M |
|---|---|
| Enterprise value | $238.86M |
| Shares outstanding | 51.65M |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$82.00M |
| EBIT | -$82.44M |
| Net Income | -$82.44M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -3.32 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | -2.91 |
| EV/EBIT | -2.90 |
| P/S ratio | N/A |
| P/B ratio | 2.34 |
| Book/Share | 2.26 |
| Cash/Share | 1.10 |
| EPS | -$1.60 |
|---|---|
| ROA | -56.24% |
| ROE | -76.43% |
| Debt/Equity | 0.36 |
|---|---|
| Net debt/EBITDA | 0.19 |
| Current ratio | 6.82 |
| Quick ratio | 6.82 |